BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7635565)

  • 1. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma.
    Stenman G; Andersson H; Mandahl N; Meis-Kindblom JM; Kindblom LG
    Int J Cancer; 1995 Aug; 62(4):398-402. PubMed ID: 7635565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation (9;22)(q22;q12). A recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma.
    Hirabayashi Y; Ishida T; Yoshida MA; Kojima T; Ebihara Y; Machinami R; Ikeuchi T
    Cancer Genet Cytogenet; 1995 May; 81(1):33-7. PubMed ID: 7773957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases.
    Sciot R; Dal Cin P; Fletcher C; Samson I; Smith M; De Vos R; Van Damme B; Van den Berghe H
    Mod Pathol; 1995 Sep; 8(7):765-8. PubMed ID: 8539235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma.
    Turc-Carel C; Dal Cin P; Rao U; Karakousis C; Sandberg AA
    Cancer Genet Cytogenet; 1988 Jan; 30(1):145-50. PubMed ID: 3422040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraskeletal myxoid chondrosarcoma with neuroendocrine differentiation: a pathologic, cytogenetic, and molecular study of a case with a novel translocation t(9;17)(q22;q11.2).
    Harris M; Coyne J; Tariq M; Eyden BP; Atkinson M; Freemont AJ; Varley J; Attwooll C; Telford N
    Am J Surg Pathol; 2000 Jul; 24(7):1020-6. PubMed ID: 10895826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
    Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S
    Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study.
    Antonescu CR; Argani P; Erlandson RA; Healey JH; Ladanyi M; Huvos AG
    Cancer; 1998 Oct; 83(8):1504-21. PubMed ID: 9781944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry.
    Orndal C; Carlén B; Akerman M; Willén H; Mandahl N; Heim S; Rydholm A; Mitelman F
    Cytopathology; 1991; 2(5):261-70. PubMed ID: 1782363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
    Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
    Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
    Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.
    Attwooll C; Tariq M; Harris M; Coyne JD; Telford N; Varley JM
    Oncogene; 1999 Dec; 18(52):7599-601. PubMed ID: 10602520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11).
    Panagopoulos I; Mencinger M; Dietrich CU; Bjerkehagen B; Saeter G; Mertens F; Mandahl N; Heim S
    Oncogene; 1999 Dec; 18(52):7594-8. PubMed ID: 10602519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Der(16)t(1;16)(q21;q13) as a secondary structural aberration in yet a third sarcoma, extraskeletal myxoid chondrosarcoma.
    Day SJ; Nelson M; Rosenthal H; Vergara GG; Bridge JA
    Genes Chromosomes Cancer; 1997 Dec; 20(4):425-7. PubMed ID: 9408761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
    Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
    Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of the EWS gene to a DNA segment from 9q22-31 in a human myxoid chondrosarcoma.
    Gill S; McManus AP; Crew AJ; Benjamin H; Sheer D; Gusterson BA; Pinkerton CR; Patel K; Cooper CS; Shipley JM
    Genes Chromosomes Cancer; 1995 Apr; 12(4):307-10. PubMed ID: 7539287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
    Broehm CJ; Wu J; Gullapalli RR; Bocklage T
    Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q11) translocation presenting initially as a solid variant devoid of myxoid areas.
    Reid R; de Silva MV; Paterson L
    Int J Surg Pathol; 2003 Apr; 11(2):137-41. PubMed ID: 12754636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic manifestations of extraskeletal myxoid chondrosarcoma associated with a novel t(2;22)(q34;q12) EWS translocation in a child and a review of the literature.
    Batsis ID; Offenbacher R; Rybinski B; Pawel B; Weiser DA
    Pediatr Hematol Oncol; 2018; 35(7-8):434-441. PubMed ID: 30776935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal translocation-negative cellular extraskeletal myxoid chondrosarcoma in an adolescent female.
    Boyd AS
    J Cutan Pathol; 2012 Sep; 39(9):872-6. PubMed ID: 22804337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
    Wang WL; Mayordomo E; Czerniak BA; Abruzzo LV; Dal Cin P; Araujo DM; Lev DC; López-Terrada D; Lazar AJ
    Mod Pathol; 2008 Nov; 21(11):1303-10. PubMed ID: 18587326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.